MAPK8 and metabolic dysfunction-associated steatohepatitis: In this regard, our results support the fact that WNT5A and JNK are upregulated in NAFLD, triggering noncanonical WNT signaling that promotes liver damage [21], but we could not demonstrate that this pathway is increased in an advanced stage of NAFLD, such as NASH.